Besides weight loss, Wegovy offers the following benefits: Heart Protection : It is the first weight-loss drug specifically licensed to reduce the risk of heart attack, stroke, and cardiovascular death by 20% in people with heart disease
None is objectively superior
For non-overweight patients considering GLP-1 therapy, understanding the clinical criteria your provider usesand what biomarker and genetic context might inform treatment decisionssupports more personalized, evidence-based care
Cell-level Weight: ~9,200 Da (approximately 9117.60 g/mol) Sequence: 83 amino acids with N-terminal extension Storage: -20C (freeze-dried), 2-8C (mixed) Shelf Life: 2-3 years (freeze-dried), 30 days (mixed)
Semaglutide Context: Same active ingredient as Wegovy (which retails for ~$1,350/mo without insurance)